{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:14:03Z","timestamp":1765484043754,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BIO2008-01985","PSE-010000-2007-4","PSE-010000-2008-4"],"award-info":[{"award-number":["BIO2008-01985","PSE-010000-2007-4","PSE-010000-2008-4"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["IPT-300000-2010-0017"],"award-info":[{"award-number":["IPT-300000-2010-0017"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.nbt.2016.10.011","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T04:30:17Z","timestamp":1477974617000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Alba","family":"Casamayor-Genesc\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnau","family":"Pla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Oliver-Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e8lia","family":"Pujals-Fonts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Mar\u00edn-Gall\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Caminal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Pujol-Autonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Carrascal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Vives-Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Vives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nbt.2016.10.011_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/107327481101800403","article-title":"Umbilical cord blood transplantation for the treatment of hematologic malignancies","volume":"18","author":"Brunstein","year":"2011","journal-title":"Cancer Control"},{"issue":"3","key":"10.1016\/j.nbt.2016.10.011_bib0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clim.2008.02.008","article-title":"Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution","volume":"127","author":"Brown","year":"2008","journal-title":"Clin Immunol"},{"issue":"22","key":"10.1016\/j.nbt.2016.10.011_bib0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nbt.2016.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.nbt.2016.10.011_bib0025","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.bbmt.2009.11.001","article-title":"New approaches for improving engraftment after cord blood transplantation","volume":"16","author":"Rocha","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.nbt.2016.10.011_bib0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","article-title":"Transplantation of ex vivo expanded cord blood","volume":"8","author":"Shpall","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.nbt.2016.10.011_bib0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.2080","article-title":"Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution","volume":"16","author":"Delaney","year":"2010","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.nbt.2016.10.011_bib0040","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3727\/096368910X552853","article-title":"Clinical-scale cultures of cord blood CD34+ cells to amplify committed progenitors and maintain stem cell activity","volume":"20","author":"Ivanovic","year":"2011","journal-title":"Cell Transplant"},{"issue":"10","key":"10.1016\/j.nbt.2016.10.011_bib0045","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0301-472X(00)00520-8","article-title":"Increased expansion and differentiation of cord blood products using a two-step expansion culture","volume":"28","author":"McNiece","year":"2000","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.nbt.2016.10.011_bib0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bmt.2008.329","article-title":"Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor","volume":"43","author":"Bautista","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.nbt.2016.10.011_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.beha.2010.05.002","volume":"23","author":"Sebrango","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"10.1016\/j.nbt.2016.10.011_bib0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1634\/stemcells.2006-0256","article-title":"In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+ 38- 33+ 90+ 45RA\u2212","volume":"25","author":"Vanheusden","year":"2007","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.nbt.2016.10.011_bib0065","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1537-2995.2006.01001.x","article-title":"Large-scale expansion and transplantation of CD34+ hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity","volume":"46","author":"Boiron","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.nbt.2016.10.011_bib0070","series-title":"Guide to cell therapy GxP: quality standards in the development of cell-based medicines in non-pharmaceutical environments","first-page":"49","article-title":"Nonclinical studies for cell-based medicines","author":"Sharpe","year":"2015"},{"issue":"August (8)","key":"10.1016\/j.nbt.2016.10.011_bib0075","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jcyt.2015.02.002","article-title":"Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments","volume":"17","author":"Vives","year":"2015","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.nbt.2016.10.011_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines","volume":"34","author":"Keeney","year":"1998","journal-title":"Cytometry"},{"issue":"9","key":"10.1016\/j.nbt.2016.10.011_bib0085","first-page":"657","article-title":"Flow cytometric analysis of human bone marrow. III. Neutrophil maturation","volume":"4","author":"Terstappen","year":"1990","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.nbt.2016.10.011_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14653240310000119","article-title":"Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells","volume":"5","author":"De Bruyn","year":"2003","journal-title":"Cytotherapy"},{"issue":"January (1)","key":"10.1016\/j.nbt.2016.10.011_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcyt.2015.10.001","article-title":"Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton\u2019s jelly","volume":"18","author":"Oliver-Vila","year":"2016","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.nbt.2016.10.011_bib0100","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R\u03b3null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.nbt.2016.10.011_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1357-4310(99)01464-1","article-title":"Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate","volume":"5","author":"Domen","year":"1999","journal-title":"Mol Med Today"},{"key":"10.1016\/j.nbt.2016.10.011_bib0110","first-page":"13","article-title":"Bone marrow (hematopoietic) stem cells","author":"Domen","year":"2006","journal-title":"Regen Med"},{"issue":"23","key":"10.1016\/j.nbt.2016.10.011_bib0115","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1101\/gad.1602607","article-title":"The hematopoietic stem cell and its niche: a comparative view","volume":"21","author":"Martinez-Agosto","year":"2007","journal-title":"Genes Dev"},{"issue":"7193","key":"10.1016\/j.nbt.2016.10.011_bib0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature07038","article-title":"Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal","volume":"453","author":"Zon","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2016.10.011_bib0125","series-title":"The stem cell research community","article-title":"Cord blood hematopoietic stem cell transplantation","author":"Broxmeyer","year":"2010"},{"issue":"10","key":"10.1016\/j.nbt.2016.10.011_bib0130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/bmt.2009.280","article-title":"History of cord blood transplantation","volume":"44","author":"Gluckman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1 Suppl","key":"10.1016\/j.nbt.2016.10.011_bib0135","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.bbmt.2009.11.001","article-title":"New approaches for improving engraftment after cord blood transplantation","volume":"16","author":"Rocha","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.nbt.2016.10.011_bib0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/ehm.10.21","article-title":"Allogeneic hematopoietic cell transplantation: the state of the art","volume":"3","author":"Gyurkocza","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.nbt.2016.10.011_bib0145","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/303487","article-title":"Haploidentical hematopoietic stem-cell transplantation in adults","volume":"2011","author":"Alshemmari","year":"2011","journal-title":"Bone Marrow Res"},{"issue":"2","key":"10.1016\/j.nbt.2016.10.011_bib0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/stemcells.22-2-135","article-title":"Fast but durable megakaryocyte repopulation and platelet production in NOD\/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells","volume":"22","author":"Bruno","year":"2004","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.nbt.2016.10.011_bib0155","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1182\/blood.V93.11.3736","article-title":"Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells","volume":"93","author":"Piacibello","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.nbt.2016.10.011_bib0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI11519","article-title":"Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD\/SCID-beta2 microglobulin-null mice","volume":"107","author":"Glimm","year":"2001","journal-title":"J Clin Invest"},{"issue":"February (2)","key":"10.1016\/j.nbt.2016.10.011_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1423-0410.2009.01227.x","article-title":"Mesenchymal stem cells for clinical application","volume":"98","author":"Sensebe","year":"2010","journal-title":"Vox Sang"},{"issue":"February (8)","key":"10.1016\/j.nbt.2016.10.011_bib0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.nbt.2016.10.011_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-014-0061-9","article-title":"The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation","volume":"7","author":"Wang","year":"2014","journal-title":"J Hematol Oncol"},{"issue":"June (6)","key":"10.1016\/j.nbt.2016.10.011_bib0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccr.2005.05.025","article-title":"What has senescence got to do with cancer?","volume":"7","author":"Dimri","year":"2005","journal-title":"Cancer Cell"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678416325213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678416325213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:58:22Z","timestamp":1761731902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678416325213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"alternative-id":["S1871678416325213"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2016.10.011","relation":{},"ISSN":["1871-6784"],"issn-type":[{"type":"print","value":"1871-6784"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2016.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}